Devyser launches the first IVDR compliant NGS assay for thalassemia and sickle cell disease testing
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
News | October 14, 2022
Contact an expert at Devyser
If you have a question, feel free to send us a message. One of our team members will get in touch with you as soon as possible.
.jpg)
Devyser acquires Swedish company Cybergene AB and strengthens its position in the aneuploidy market
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Devyser enters Strategic Supply Agreement with Illumina to offer sequencing instruments and products
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA...
Devyser wins Norwegian tender for Devyser CFTR at Oslo University Hospital
Devyser is proud to announce that the company has been awarded a tender by Oslo University Hospital...